Zipsor

Type: Product
Name: Zipsor
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Depomed Announces District Court Order in ANDA Litigation

NEWARK, Calif.On May 20, 2014, a bench trial was completed before Judge Pisano in the patent litigation between Depomed and defendants Actavis Elizabeth LLC and Actavis Inc. related to an Abbreviated New Drug Application filed by Actavis seeking to market ... [Published Bio-Medicine - Jul 17 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Depomed Announces Appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer

SOURCE Depomed, Inc.NEWARK, Calif. , July 16, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced the appointment of Srinivas G. Rao , MD, PhD, as Chief Medical Officer and Senior Vice President.   Dr. Rao has extensive experience and background ... [Published KSFY - Jul 16 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Tulsa, OK-Pharmaceutical Sales Representative

OverviewinVentiv Health offers best-in-class Clinical, Consulting and Commercial services to global companies seeking to accelerate performance. With 13,000 employees in 40 countries, we rapidly transform promising ideas into commercial reality. inVentiv ... [Published PharmaDiversity - Jul 16 2014]
First reported Jun 22 2014 - Updated Jun 22 2014 - 1 reports

ZIPSOR (Diclofenac Potassium) Capsule, Liquid Filled [Depomed, Inc.]

Entities: Zipsor, Depomed Inc
First reported Jun 18 2014 - Updated Jun 18 2014 - 1 reports

Depomed To Present AT JMP Securities 2014 Healthcare Conference

Related Stocks DEPO - Depomed IncSym Last Chg Pct Volume DEPO13.00-0.17-1.29%925,500 NEWARK, Calif. , June 18, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the JMP Securities 2014 Healthcare Conference ... [Published Barchart - Jun 18 2014]

Quotes

"I am extremely pleased to be joining Depomed at this exciting time in the company's history," said Dr. Rao.  "I believe that Jim and the team at Depomed have accomplished a tremendous amount in the past few years and continue to move towards a leadership position in the field of pain and CNS related products.  I look forward to helping the company achieve that goal."
"We recognize that patients with breakthrough cancer pain face many challenges, including reimbursement and access issues" said Jim Schoeneck President

More Content

All (8) | News (6) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Buffalo, NY- Pharmaceutical Sales Representative [Published PharmaDiversity - Jul 23 2014]
Depomed Announces District Court Order in ANDA ... [Published Bio-Medicine - Jul 17 2014]
Depomed Announces District Court Order in ANDA ... [Published KSFY - Jul 17 2014]
Depomed Announces Appointment of Srinivas G. Ra... [Published KSFY - Jul 16 2014]
Tulsa, OK-Pharmaceutical Sales Representative [Published PharmaDiversity - Jul 16 2014]
ZIPSOR (Diclofenac Potassium) Capsule, Liquid F... [Published DailyMed Drug Label Updates for the last seven ... - Jun 22 2014]
Depomed To Present AT JMP Securities 2014 Healt... [Published Barchart - Jun 18 2014]
Depomed Announces the Launch of Lazanda® (fenta... [Published PR Newswire - Oct 28 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ZIPSOR (Diclofenac Potassium) Capsule, Liquid F... [Published DailyMed Drug Label Updates for the last seven ... - Jun 22 2014]
Updated Date: Jun 18, 2014 EST ...
1

Press Releases

sort by: Date | Relevance
Depomed Announces the Launch of Lazanda® (fenta... [Published PR Newswire - Oct 28 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.